4//SEC Filing
Gjino Anjeza 4
Accession 0001140361-21-006649
CIK 0001755237other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:23 PM ET
Size
5.0 KB
Accession
0001140361-21-006649
Insider Transaction Report
Form 4
Gjino Anjeza
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-02-25$4.00/sh−1,824$7,296→ 31,599 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $4.00, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
Cyclerion Therapeutics, Inc.
CIK 0001755237
Entity typeother
Related Parties
1- filerCIK 0001839068
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:23 PM ET
- Size
- 5.0 KB